News Conference News TCT 2020 Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows Caitlin E. Cox October 14, 2020
News Daily News Don’t Mistake Microthrombi for Myocarditis in COVID-19 STEMI, Case Report Warns Caitlin E. Cox July 22, 2020
News Daily News COVID-19’s Kawasaki-Like MIS-C Diagnosis Is Cropping Up in Adults Shelley Wood July 22, 2020
News Daily News Even Very Sick Kids Fare Well Despite Kawasaki-Like COVID-19 Symptoms Todd Neale May 21, 2020
News Features Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms Caitlin E. Cox April 23, 2020
News Opinion Editor's Corner COVID-19 and the Heart: Insights From the Front Lines Shelley Wood March 12, 2020
News Daily News Omega-3 PUFAs Offset Adverse CV Effects of Air Pollution in Small, Chinese Study Michael O'Riordan April 24, 2019
News Conference News AHA 2018 Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis Caitlin E. Cox November 13, 2018
News Conference News AHA 2018 Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT Michael O'Riordan November 10, 2018
News Daily News ‘Just Move’: Registry Study Shows Positive CV Effects of Light Physical Activity in Older Adults Yael L. Maxwell August 08, 2018
News Daily News ESC Consensus Statement Tackles Inflammation, Cholesterol Connection in a Post-CANTOS World Caitlin E. Cox May 16, 2018
News Conference News ACC 2018 Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS Michael O'Riordan March 12, 2018
News Conference News AHA 2017 CANTOS: Big Drop in CVD Events Among Canakinumab Responders Michael O'Riordan November 13, 2017
News Daily News Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests Michael O'Riordan October 20, 2017
News Conference News ESC 2017 CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events Michael O'Riordan August 27, 2017